GlassScriptPhysician profile
Peter F Chen
NPI 1184184996
$4,435.78
in general payments reported to CMS, 2019-2025
14 companies · $321 in 2025
The $321 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $273 · 2020: $154 · 2021: $403 · 2022: $1,045 · 2023: $2,070 · 2024: $170 · 2025: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,445 · Travel and Lodging: $1,116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,444.92 |
| Travel and Lodging | $1,116.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,036.08 | 2019-2025 | Clareon, Hydrus Microstent, Wavelight Ex500 Excimer Laser |
| Regeneron Healthcare Solutions, INC. | $293.34 | 2022-2024 | Eylea, Eylea Hd |
| Abbvie INC. | $203.11 | 2024-2025 | |
| Sight Sciences, INC. | $147.15 | 2023-2024 | Omni Surgical System |
| Allergan, INC. | $146.27 | 2020-2021 | |
| Genentech USA, INC. | $129.12 | 2022 | |
| Haag-Streit USA, INC. | $115.43 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $98.81 | 2023-2025 | Tecnis Simplicity, Amo Phaco Needle |
| Apellis Pharmaceuticals, INC. | $88.17 | 2022 | |
| Biotissue Holdings INC. | $42.94 | 2023 | |
| Bausch & Lomb Americas INC. | $40.12 | 2025 | Vyzulta |
| Glaukos Corporation | $37.82 | 2023 | Photrexa Cross-Linking Kit |
| Tarsus Pharmaceuticals, INC. | $36.72 | 2024-2025 | Xdemvy |
| Spark Therapeutics, INC. | $20.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.